China Cord Blood Corp Revenue, Profits - CO Quarterly Income Statement

Add to My Stocks
$10.52 $0.2 (1.87%) CO stock closing price Feb 16, 2018 (Closing)

Fundamental analysis of CO stock involves analyzing its financial statements, apart from checking the China Cord Blood Corp stock price. The income statement gives the investor an understanding of the topline or revenue and bottomline or profit numbers of the company and helps investors evaluate if a company has been growing or not. The income statement for CO which shows a YOY revenue growth of 6.62% is specific to a period of time. Investors typically check YoY or QoQ revenue growth. One also needs to look at China Cord Blood Corp assets, operating expenses and China Cord Blood Corp free cash flow. The China Cord Blood Corp profit and loss statement shows revenue of $35.26M for 2018 Q2. Revenue has grown by 6.62% QoQ for CO stock.

View and download details of revenue and profits for China Cord Blood Corp for latest & last 40 quarters.
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Apr - Mar2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q2
China Cord Blood Corp Revenues or Net Sales
35.26M33.07M29.35M28.93M27.61M26.02M24.31M26.15M26.98M
Cost Of Goods Sold (COGS)6.86M6.6M5.62M3.61M5.86M5.63M5.1M5.58M5.85M
China Cord Blood Corp Gross Profit
28.39M26.46M22.23M25.31M21.75M20.39M17.94M20.56M21.12M
Research & Development Expense---------
Selling General & Admin Expense16.37M13.83M14.02M10.25M13.18M12.25M11.85M12.32M12.52M
Income Before Depreciation Depletion Amortization11.47M12.23M7.8M14.64M8.2M7.84M5.78M7.83M8.25M
Depreciation Depletion Amortization---------
Non Operating Income1.03M-1.29M----6.41M-
Interest Expense--4.15M4.4M4.46M4.33M4.15M4.29M4.13M
China Cord Blood Corp Pretax Income
12.5M12.63M4.93M10.55M4.49M4.19M2.38M9.95M4.99M
Provision for Income Taxes2.18M2.31M-0.65M2.47M1.89M1.75M1.23M2.1M2.01M
MinorityInterest-------0.03M--
Investment Gains Losses---------
Other Income---------
Income Before Extraordinaries & Disc Operations10.16M10.2M5.51M8.05M2.5M2.37M1.28M7.79M2.95M
Extraordinary Items & Discontinued Operations---------
China Cord Blood Corp Profit/ Loss (Net Income)
10.16M10.2M5.51M8.05M2.5M2.37M1.28M7.79M2.95M
Average Shares used to compute Diluted EPS112.88M113.31M78.73M80.49M83.2M78.9M73M73.14M73.65M
Average Shares used to compute Basic EPS112.88M113.31M78.73M80.49M83.2M78.9M73M73.14M73.65M
Income Before Nonrecurring Items10.16M10.2M5.51M8.05M2.5M2.37M1.28M7.79M3.8M
Income from Nonrecurring Items---------0.86M
China Cord Blood Corp Earnings Per Share Basic Net
0.090.090.070.100.030.030.030.100.04
China Cord Blood Corp Earnings Per Share Diluted Net
---------
EPS Diluted Before Nonrecurring Items0.090.090.070.100.030.030.030.100.05
Preferred Dividends Acc Pd---------
Dividends Common0.00--------
Dividend Per Share Common0.000.000.000.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Before investing one should read a report on China Cord Blood Corp stock analysis. It helps to look at the following income statement items:

  • Topline: A growing topline, as seen from the China Cord Blood Corp revenue chart, as is the case with China Cord Blood Corp indicates a growing business. One needs to compare the QoQ topline or sales growth of CO stock with its peers like SCAI stock and AMED stock to see if the growth compares well with what can be expected from a company in that industry.
  • Bottom line: The bottomline or the net income figure is arrived at by deducting all expenses from the topline which in this case is $10.16M for CO stock. An improving bottomline implies that the company is growing its profits.

The income statement is also called the profit and loss statement. Apart from the CO income statement, one can check the China Cord Blood Corp historical stock prices to check how the price has moved with time.

China Cord Blood Corp Income Statement - Key Financial Ratios

PE Ratio (price earnings ratio)
30.06
PS Ratio (price sales ratio)
9.38
Operating Margin
32.5
Net Profit Margin
28.8
Dividend Yield
0%